Rehmann Capital Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.21M | Buy |
|
|||||
|
2025
Q2 | $884K | Buy |
|
|||||
|
2025
Q1 | $921K | Buy |
|
|||||
|
2024
Q4 | $487K | Buy |
|
|||||
|
2024
Q3 | $572K | Sell |
|
|||||
|
2024
Q2 | $663K | Buy |
|
|||||
|
2024
Q1 | $578K | Buy |
|
|||||
|
2023
Q4 | $461K | Buy |
|
|||||
|
2023
Q3 | $397K | Buy |
|
|||||
|
2023
Q2 | $333K | Buy |
|
|||||
|
2023
Q1 | $370K | Buy |
|
|||||
|
2022
Q4 | $289K | Sell |
|
|||||
|
2022
Q3 | $319K | Buy |
|
|||||
|
2022
Q2 | $269K | Sell |
|
|||||
|
2022
Q1 | $696K | Buy |
|
|||||
|
2021
Q4 | $601K | Buy |
|
|||||
|
2021
Q3 | $546K | Buy |
|
|||||
|
2021
Q2 | $490K | Sell |
|
|||||
|
2021
Q1 | $472K | Buy |
|
|||||
|
2020
Q4 | $442K | Buy |
|
|||||
|
2019
Q3 | $1.94K | Sell |
|
|||||
|
2019
Q2 | $3.76K | Sell |
|
|||||
|
2019
Q1 | $86.2K | Buy |
|
|||||
|
2018
Q4 | $59.8K | Buy |
|
|||||
|
2018
Q3 | $29.1K | Buy |
|
|||||
|
2018
Q2 | $1.38K | Sell |
|
|||||
|
2018
Q1 | $17K | Buy |
|